METHOD FOR CARRYING OUT PLEURODESIS IN THE CASES OF MALIGNANT TUMOR PLEURITIS

medicine. SUBSTANCE: method involves introducing collagen powder into the pleural cavity in the amount of 1.0-1.5 g as suspension in physiological sodium chloride solution. 10- 15 ml of 2% Lidocaine solution is additionally added to the suspension for making pleural cavity anesthesia and preventing...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VARLAMOV V.V, PUKHOVA Z.I, LEVASHEV JU.N, AKOPOV A.L
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine. SUBSTANCE: method involves introducing collagen powder into the pleural cavity in the amount of 1.0-1.5 g as suspension in physiological sodium chloride solution. 10- 15 ml of 2% Lidocaine solution is additionally added to the suspension for making pleural cavity anesthesia and preventing pain syndrome when contacting to collagen particles. EFFECT: enhanced effectiveness of pleurodesis; avoided pain syndrome and temperature response; prevented recidivation. 3 cl